GEN Exclusives

More »

GEN News Highlights

More »
Jul 29, 2011

Fred Hutchinson Center Awarded $8.2M to Coordinate Obesity and Cancer Consortium

  • The Fred Hutchinson Cancer Research Center has been awarded $8.2 million from the National Cancer Institutes to coordinate a national U.S. research consortium focused on investigating the links between obesity and cancer. The $45 million Transdisciplinary Research on Energetics and Cancer (Trec) Initiative also aims to study underlying behavioral causes of obesity and identify potential preventive measures, particularly among children, cancer patients, and others at high risk.

    While the Hutchinson Center is coordinating the program, five-year research funding will also be provided to Trec project collaborators at Harvard University, University of California San Diego, University of Pennsylvania, and Washington University in St. Louis. Research projects will range from biological and physiological mechanisms of obesity, to behavioral, socio-cultural, and environmental influences on nutrition, physical activity, and weight.

    “By approaching the problem from many directions and collaborating across studies we hope to make scientific progress faster than more narrowly focused research,” comments Mark Thornquist, Ph.D., principal investigator at the Hutchinson Center’s Public Health Sciences Division. “The idea behind Trec was to attack the problem of obesity and cancer with teams of researchers from many scientific fields such as nutrition science, molecular epidemiology, and behavioral science.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?